A new survey reveals the most important elements for a successful partnership between pharma and clinical research organisations
Featuring: The UK election and Pharma - Brexit and the EMA's relocation - The future of the Pharma-CRO relationship
Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Wearables are here to stay – and pharma shouldn't ignore this golden opportunity
The Medicines and Healthcare products Regulatory Agency has cleared the adjuvanted trivalent influenza vaccine Fluad for use in people aged 65 years or older.
22nd August 2017
Novartis has kicked off a mobile research study for people with multiple sclerosis (MS) that collects data remotely via their smartphone.
22nd August 2017
Samsung Bioepis is joining forces with Takeda Pharmaceutical to jointly fund and co-develop multiple novel biologic therapies in unmet disease areas, taking its first step towards developing new pharmaceuticals.
22nd August 2017
Johnson & Johnson has been ordered by a jury in California to pay $417 million to a woman who claims to have developed ovarian cancer from regular use of its talc-based products.
22nd August 2017
Due to unprecedented demand, the prestigious PharmaTimes Communications Team of the Year 2017 competition is now fully booked.
22nd August 2017
Joseph B. Laudano, vice president, medical affairs strategy for Medmeme, takes a look at advances in data mining and metrics analysis
In a world of increasingly complex pharma supply chains, technology is playing a growing role in helping smooth the relationship between businesses and their suppliers
A detailed look at the ongoing patent case for Pfizer’s pain drug and what the potentially-landmark ruling could mean for the industry
With Brexit negotiations beginning, Catalyst Corporate Finance’s Tom Cowap argues that Britain's divorce from the EU could actually give a major boost to the UK’s pharma sector
Post-election jitters have struck pharma after a surprise result for the UK. With Brexit on the horizon and a minority government in charge, has the industry’s optimism been dashed?
What does the EMA’s move from London mean for the competitiveness of the UK pharmaceutical industry?
How the recent UK election could affect the NHS
Sue Thomas, Paul Midgley and Steve How, of Wilmington Healthcare, explain how pharma can work with the NHS to transform services
Improving the care of diabetes patients at City Hospitals Sunderland - a joint working initiative with Lilly
Engaging digital while retaining a human touch
Sanofi’s general manager for the UK and Ireland Hugo Fry on leading a company through transitional times
Richard Baderin, head of commercial enterprises at Accretio, on making the most of your resources
Across all industries, people are changing the ways they engage with products, services, and brands. View more...
Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW
